
Sara Tolaney/X
Apr 27, 2025, 15:48
Sara Tolaney: Excellent overview of treatment for early stage HER2 positive disease
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a post on X:
“Excellent overview of treatment for early stage HER2 positive disease by Mothaffar Rimawi – we need biomarkers to tailor therapy for this population.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 22, 2025, 17:32
May 22, 2025, 17:25
May 22, 2025, 16:22
May 22, 2025, 15:55